ET
MRNA icon

Equitable Trust’s Moderna MRNA Stock Holding History

Equitable Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,639
Closed -$313K – 451
2024
Q2 		$313K Sell
2,639
-1,387
-34% -$176K 0.02% 375
2024
Q1 		$429K Sell
4,026
-1,606
-29% -$162K 0.03% 323
2023
Q4 		$560K Sell
5,632
-601
-10% -$50.5K 0.04% 261
2023
Q3 		$644K Sell
6,233
-7,250
-54% -$809K 0.05% 220
2023
Q2 		$1.64M Sell
13,483
-50,742
-79% -$6.77M 0.13% 129
2023
Q1 		$9.86M Sell
64,225
-23,490
-27% -$3.88M 0.78% 28
2022
Q4 		$15.8M Sell
87,715
-6,330
-7% -$1.04M 1.24% 21
2022
Q3 		$11.1M Buy
94,045
+200
+0.2% +$30.3K 0.93% 25
2022
Q2 		$13.4M Buy
+93,845
New +$13.4M 1% 25

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Equitable Trust's MRNA Position: Q3 2024 in Review

Equitable Trust sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,639 shares — an estimated $313K sold.

Equitable Trust first reported a position in MRNA in Q2 2022 and held it in 9 quarters. The position peaked at $15.8M in Q4 2022. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Equitable Trust reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Equitable Trust sold 2,639 Moderna shares in Q3 2024, an estimated $313K.
  • Equitable Trust first reported a position in Moderna in Q2 2022 and held it in 9 quarters.
  • Equitable Trust's Moderna position peaked at $15.8M in Q4 2022.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Equitable Trust's 13F filing for Q3 2024, filed 29 Oct 2024.